Navigation Links
Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
Date:1/9/2012

LAKE FOREST, Ill., Jan. 9, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced enrollment of the first patient in a Phase III U.S. clinical program for its biosimilar erythropoietin (EPO). Hospira's Phase III program, which follows a successful Phase I trial that concluded last year, will compare safety and efficacy of Hospira's EPO and the reference product, Amgen's Epogen® in patients with renal (kidney) dysfunction who have anemia. Erythropoietin is a treatment for anemia associated with chronic renal failure.

The program will enroll approximately 1,000 patients on hemodialysis who have already been treated with Epogen, and will take place at more than 200 different hemodialysis centers across the United States. Results are expected in 2013.

"Patient enrollment in our Phase III EPO program is another important step as Hospira prepares to introduce safe, effective and affordable biosimilars in the United States,"  said Sumant Ramachandra, M.D., Ph.D., senior vice president, Research & Development and Medical & Regulatory Affairs, and chief scientific officer, Hospira. "We look forward to offering U.S. patients access to these important medications."

Hospira already sells a biosimilar EPO in Europe, Retacrit, and is the first and only North American-headquartered company with biosimilars on the European market and in Australia. Retacrit was introduced in early 2008, and Hospira launched Nivestim, a biosimilar version of filgrastim, in Europe in 2010 and in Australia last year. Filgrastim is a granulocyte colony-stimulating factor (G-CSF) used to treat neutropenia, a condition in which the body makes too few infection-fighting white blood cells. The condition is often ca
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 Projections
2. Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012
3. Hospira Reports Third-Quarter 2011 Results
4. Hospira Announces Certain Preliminary Third-Quarter 2011 Results
5. Hospira to Host Conference Call for Third-Quarter 2011 Results
6. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
7. Hospira to Host 2011 Investor Day
8. Hospira to Present at the Morgan Stanley Global Healthcare Conference
9. Hospira Expands Board of Directors
10. Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection
11. Hospira Reports Second-Quarter 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... Corporation (NASDAQ: THOR ), a world leader in mechanical ... announced today that Marta Antonucci has joined Thoratec ... This new Europe -based position is responsible ... America , including Europe , ... , and reports directly to the Chief Executive Officer. Following the ...
(Date:5/1/2015)... 1, 2015  CytRx Corporation (CYTR), a biopharmaceutical ... reported financial results for the three months ended ... recent accomplishments and upcoming milestones for its clinical ... in the early months of 2015, including the ... of aldoxorubicin in patients with soft tissue sarcoma, ...
(Date:5/1/2015)... The Institute for Healthcare Advancement (IHA) is ... The IHA Health Literacy Awards aim to encourage, recognize ... practice of educating or empowering organizations to deliver clear ... three categories: innovative programs, published materials and research. This ... In the area of innovative programs, the ...
Breaking Medicine Technology:Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3CytRx Reports First Quarter 2015 Financial Results 2CytRx Reports First Quarter 2015 Financial Results 3CytRx Reports First Quarter 2015 Financial Results 4CytRx Reports First Quarter 2015 Financial Results 5CytRx Reports First Quarter 2015 Financial Results 6CytRx Reports First Quarter 2015 Financial Results 7CytRx Reports First Quarter 2015 Financial Results 8CytRx Reports First Quarter 2015 Financial Results 9CytRx Reports First Quarter 2015 Financial Results 10CytRx Reports First Quarter 2015 Financial Results 11Institute for Healthcare Advancement Announces 2015 Award Winners 2
... SYDNEY, May 23, 2011 Starpharma Holdings Limited (ASX: ... major phase 2 clinical study that demonstrated efficacy of ... Key Points: VivaGel(R) ... BV VivaGel(R) expected to avoid many shortcomings of ...
... Advanced Life Sciences Holdings, Inc. ... its Annual Meeting of Shareholders, which was previously scheduled ... (Logo:   http://photos.prnewswire.com/prnh/20080218/ALSLOGO ) ... Sciences is a biopharmaceutical company engaged in the discovery, ...
Cached Medicine Technology:VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis 2VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis 3VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis 4VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis 5
(Date:5/2/2015)... As one of only 30 Illinois ... and Health Achievement and Recognition Program (SHARP) certification, ... by the Illinois Department of Labor to host this ... SHARP certification by the Occupational Safety and Health Administration’s ... continued to meet or exceed all of the necessary ...
(Date:5/2/2015)... NY (PRWEB) May 02, 2015 It’s ... a deadly natural disaster strikes anywhere on this planet, ... leverage human sympathy and compassion for their own personal ... States Computer Emergency Readiness Team) issued an alert ... “of potential email scams citing the earthquake in Nepal. ...
(Date:5/2/2015)... TX (PRWEB) May 02, 2015 ... skin laxity issues of the face, neck and ... new concept with real potential for the success ... by the ThermiHealth Clinical Advisory Council, ThermiGyn’s Women’s ... FACOG, FACS, ACGE, concluded that ThermiGyn’s temperature controlled ...
(Date:5/1/2015)... 2015 Pioneer Millworks, the largest reclaimed ... in their reclaimed wood products at the 27th annual ... Center in NYC this May. Their newest offerings, Vat ... anticipated texture and color to North America's platform for ... texture and color in the design world and we're ...
(Date:5/1/2015)... May 01, 2015 It’s raining bills on ... introducing proposals to expand federal support for telemedicine. ... ATA has been working with Congress,” said Jonathan Linkous, CEO ... how the nation is poised to embrace the use of ... more step in fulfilling ATA’s mission to improve quality, access, ...
Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2
... 27 (HealthDay News) -- Disabled adults are at higher ... aren,t disabled, new research finds. Those with mental ... having experienced physical, sexual or "intimate partner" violence during ... Feb. 27 in The Lancet . For ...
... warranted for older men with prostate cancer and a short ... Feb. 27 Archives of Internal Medicine. ... said senior author on the study Cary Gross, M.D., associate ... men who are older and have less aggressive forms of ...
... HealthDay Reporter , MONDAY, Feb. 27 (HealthDay News) -- ... want to look out. That,s the message of a new ... are more likely to cut off pedestrians and ignore stop-sign ... habits, either. Other lab-based experiments done by the researchers found ...
... 27 (HealthDay News) -- A potentially dangerous heart rhythm problem ... physical decline in older people at risk for heart disease, ... in the Canadian Medical Association Journal , researchers analyzed ... 40 countries, aged 55 and older. All of the participants ...
... at Harbor-UCLA Medical Center (LA BioMed) recently announced that ... of the Center for Reproduction and Infertility at Women ... Center, as one of its three "Legends" this May. ... recognized contributions to medicine through research and innovative clinical ...
... that patients with chronic myeloid leukemia (CML) who have ... they switch to the targeted drug imatinib. Published early ... the American Cancer Society, the study indicates that imatinib ... Imatinib, a drug that blocks the protein made by ...
Cached Medicine News:Health News:Disabled Adults More Apt to Be Victims of Violence: Study 2Health News:Prostate cancer treatment overused in some older patients 2Health News:Are the Rich Really Different From You and Me? 2Health News:Are the Rich Really Different From You and Me? 3Health News:Irregular Heartbeat May Predict Mental Decline in Some 2Health News:Physician to be honored as 'Legend' 2Health News:Physician to be honored as 'Legend' 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: